Publicaciones en las que colabora con OCTAVIO CABA PÉREZ (49)

2023

  1. Nutritional status assessment in patients with chronic pancreatitis

    Progress in Nutrition, Vol. 25, Núm. 4

  2. Predicting COVID-19 Severity Integrating RNA-Seq Data Using Machine Learning Techniques

    Current Bioinformatics, Vol. 18, Núm. 3, pp. 221-231

  3. Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis

    NMR in Biomedicine, Vol. 36, Núm. 9

2022

  1. Chronic pancreatitis: analysis of disease progression factors

    Revista Medica de Chile, Vol. 150, Núm. 12, pp. 1555-1564

2021

  1. Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  2. Liquid biopsy approach to pancreatic cancer

    World Journal of Gastrointestinal Oncology, Vol. 13, Núm. 10, pp. 1263-1287

  3. Untargeted metabolomics for the diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis

    Medicina (Lithuania), Vol. 57, Núm. 9

2020

  1. Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics

    Cancers, Vol. 12, Núm. 4

  2. MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

    Journal of Biosciences, Vol. 45, Núm. 1

  3. Novel biomarkers to distinguish between type 3c and type 2 diabetes mellitus by untargeted metabolomics

    Metabolites, Vol. 10, Núm. 11, pp. 1-12

  4. Role of exocrine and endocrine insufficiency in the management of patients with chronic pancreatitis

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-12

  5. State of the art in exocrine pancreatic insufficiency

    Medicina (Lithuania), Vol. 56, Núm. 10, pp. 1-10

  6. Towards Improving Skin Cancer Diagnosis by Integrating Microarray and RNA-Seq Datasets

    IEEE Journal of Biomedical and Health Informatics, Vol. 24, Núm. 7, pp. 2119-2130

2019

  1. Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level

    PLoS ONE, Vol. 14, Núm. 2

  2. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

    PLoS ONE, Vol. 13, Núm. 4

  2. Proteomic biomarkers in body fluids associated with pancreatic cancer

    Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587

2017

  1. Untargeted LC-HRMS-based metabolomics for searching new biomarkers of pancreatic ductal adenocarcinoma: A pilot study

    SLAS Discovery, Vol. 22, Núm. 4, pp. 348-359

2016

  1. Current status of immunotherapy treatments for pancreatic cancer

    Journal of Clinical Gastroenterology, Vol. 50, Núm. 10, pp. 836-848

  2. Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients

    Toxicology and Applied Pharmacology, Vol. 311, pp. 113-116